Clinical Trial Update: Nivolumab With Gemcitabine, Oxaliplatin + Rituximab in r/r Elderly Lymphoma Patients [Phase 2, Phase 3]

View source ↗

Summary

Completed Phase 2/Phase 3 trial evaluating nivolumab with gemcitabine, oxaliplatin, and rituximab in elderly patients with relapsed/refractory Non-Hodgkin lymph…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-hodgkin Lymphoma

Drugs mentioned

• Eloxatin (oxaliplatin)
• Gemzar (gemcitabine)
• OPDIVO (nivolumab)
• Rituxan (rituximab)

Snippet

Sponsor: Universität des Saarlandes | Conditions: Lymphoma, Non-Hodgkin | Phase 2, Phase 3 | Status: COMPLETED